Fe-bLf-Dox treated mice had significantly reduced the UGT weight than control mice (P < 0.001) thereby suggesting that Fe-bLf-Dox was more effective in inhibiting tumour development than Dox alone injections, which showed no significant reduction in tumour weight in comparison to control (Fig. 6C). This evidence concerns the gene SLC35A2 and neoplasm.